Quantification of urinary o,o′-dityrosine, a biomarker for oxidative damage to proteins, by high performance liquid chromatography with triple quadrupole tandem mass spectrometryA comparison with ion-trap tandem mass spectrometry

Journal of Chromatography B
2005.0

Abstract

We recently described an isotope dilution reversed-phase liquid chromatography-atmospheric pressure chemical ionization-ion-trap-tandem mass spectrometry (HPLC-APCI-MS/MS) method for the quantitative determination of oxidized amino acids in human urine, including o,o'-dityrosine, a specific marker of protein oxidation. In the present study, we investigated the possibility to use a triple quadrupole instrument for the analysis of this biomarker in urine. The two instruments were compared in terms of sensitivity, specificity and reproducibility. Results showed that the triple quadrupole instrument reaches 2.5-fold higher sensitivity (LOD=0.01 microM) compared to the previously used ion-trap instrument. Precision of the present assay is as follows: in-day variation is 4.6% and inter-day variation is 17%. The currently developed method was applied to a group of smoker urine samples. The mean urinary o,o'-dityrosine concentration was 0.08+/-0.01 microM. Expressed per urinary creatinine concentration, this corresponds to 10.1+/-0.4 micromol/mol creatinine. This is comparable to the previously reported values of 5.8+/-0.3 micromol/mol creatinine in non-smokers night-time urines, and 12.3+/-5 micromol/mol creatinine in day-time urines measured by the ion-trap instrument.

Knowledge Graph

Similar Paper

Quantification of urinary o,o′-dityrosine, a biomarker for oxidative damage to proteins, by high performance liquid chromatography with triple quadrupole tandem mass spectrometryA comparison with ion-trap tandem mass spectrometry
Journal of Chromatography B 2005.0
A rapid and sensitive method for quantitation of nucleosides in human urine using liquid chromatography/mass spectrometry with direct urine injection
Rapid Communications in Mass Spectrometry 2004.0
Measurement of endogenous uracil and dihydrouracil in plasma and urine of normal subjects by liquid chromatography–tandem mass spectrometry
Journal of Chromatography B 2002.0
A High-Performance Liquid Chromatography Method for the Detection of Diaminopimelic Acid in Urine
Analytical Biochemistry 2001.0
Simultaneous determination of mercapturic acids derived from ethylene oxide (HEMA), propylene oxide (2‐HPMA), acrolein (3‐HPMA), acrylamide (AAMA) and <i>N,N</i>‐dimethylformamide (AMCC) in human urine using liquid chromatography/tandem mass spectrometry
Rapid Communications in Mass Spectrometry 2008.0
Gas chromatographic–mass spectrometric determination of urinary oxoacids using O-(2,3,4,5,6-pentafluorobenzyl)oxime-trimethylsilyl ester derivatization and cation-exchange chromatography
Journal of Chromatography B: Biomedical Sciences and Applications 1998.0
Identification of O-phosphoamino acids in urine hydrolysate by gas chromatography—mass spectrometry
Journal of Chromatography B: Biomedical Sciences and Applications 1993.0
Comprehensive Detection of Disorders of Purine and Pyrimidine Metabolism by HPLC with Electrospray Ionization Tandem Mass Spectrometry
Clinical Chemistry 2006.0
Analysis of free and bound <i>O</i>‐phosphoamino acids in urine by gas chromatography with flame photometric detection
Biomedical Chromatography 1993.0
Development and validation of a liquid chromatography–tandem mass spectrometry assay for the analysis of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and its metabolite 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine (N-OH-PhIP) in plasma, urine, bile, intestinal contents, faeces and eight selected tissues from mice
Journal of Chromatography B 2010.0